1
Clinical Trials associated with UCB-3101A First-in-Human, Randomized, Investigator-Blind, Participant-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of UCB3101 in Healthy Participants
The purpose of the study is to evaluate the safety and tolerability of a single ascending dose of UCB3101 in cohorts of healthy male and female study participants.
100 Clinical Results associated with UCB-3101
100 Translational Medicine associated with UCB-3101
100 Patents (Medical) associated with UCB-3101
100 Deals associated with UCB-3101